This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Terumo Neuro
Terumo Neuro, a division of Terumo Corporation, is a leading player in the neurovascular industry, headquartered in the United States. Founded in 1921, Terumo has established itself as a pioneer in medical technology, with significant operations across North America and Europe. The company focuses on innovative solutions for neurovascular interventions, offering a range of products including embolisation devices, stent retrievers, and access systems. What sets Terumo Neuro apart is its commitment to advancing patient care through cutting-edge technology and research-driven approaches. The company has achieved notable milestones, including the development of unique devices that enhance procedural efficiency and safety. With a strong market position, Terumo Neuro continues to be recognised for its contributions to the field, making significant strides in improving outcomes for patients with neurovascular conditions.
DitchCarbon Score
How does Terumo Neuro's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Terumo Neuro's score of 63 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Terumo Neuro, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family that includes Terumo Corporation, from which it inherits climate commitments and initiatives. Terumo Corporation has set ambitious climate targets, which are cascaded down to Terumo Neuro. These commitments include participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), reflecting a commitment to reducing greenhouse gas emissions in line with global climate goals. While specific reduction targets for Terumo Neuro are not detailed, the overarching initiatives from Terumo Corporation suggest a proactive approach to sustainability and climate action. The company is expected to align its practices with industry standards, focusing on reducing emissions across all scopes, particularly Scope 1 and 2, which pertain to direct and indirect emissions from owned or controlled sources. As Terumo Neuro continues to develop its climate strategy, it is positioned to contribute to the broader goals of its parent company, Terumo Corporation, in addressing climate change and reducing carbon footprints.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2005 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | 0,000,000,000 | - | - | - | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Terumo Neuro is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
